Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-02-27 14:18:13
Reporting Period:
Filing Date:
Accepted Time:
2012-02-27 14:18:13
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219023 J W David Mcgirr 65 Hayden Avenue
Lexington MA 02421
Svp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-23 15,000 $12.61 32,345 No 4 M Direct
Common Stock Disposition 2012-02-23 15,000 $42.68 17,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2012-02-23 15,000 $0.00 15,000 $12.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-03-12 2013-12-12 No 4 M Direct
  1. Sold pursuant to a Rule 10(b)5-1 Plan
  2. This transaction was executed in multiple trades at prices ranging from $42.61 to $42.78. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.